Receipt of perioperative blood transfusion after surgery for renal cell carcinoma is associated with a higher risk of tumor recurrence, progression, and death. READ MORE

Conferences

Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial.

READ MORE

News

Receipt of perioperative blood transfusion after surgery for renal cell carcinoma is associated with a higher risk of tumor recurrence, progression, and death.

READ MORE

The National Comprehensive Cancer Network recently issued an updated version of their guidelines for varying histologies of kidney cancer.

READ MORE

Some health care services are rarely offered among older patients in the perioperative period for kidney cancer.

READ MORE

Genetic variants that predispose individuals to longer telomere length appear to be associated with an increased risk of renal-cell carcinoma.

READ MORE

Research in Review

Stereotactic ablative radiation therapy can achieve more than 90% control of renal cell carcinoma metastases.

READ MORE

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy.

READ MORE

Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research.

READ MORE

First-line therapy with cabozantinib was superior to standard of care sunitinib with respect to progression-free survival and objective response rate for patients with intermediate- or poor-risk metastatic renal cell carcinoma, according to a study published in the Journal of Clinical Oncology.

READ MORE